{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:32:57Z","timestamp":1794313977328,"version":"4.9.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100020523","name":"United States Drug Enforcement Administration","doi-asserted-by":"publisher","award":["15DDHQ19A00000010"],"award-info":[{"award-number":["15DDHQ19A00000010"]}],"id":[{"id":"10.13039\/100020523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Hexahydrocannabinol (HHC) recently appeared on the recreational drug market and is often sold as a legal replacement for \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -tetrahydrocannabinol (\u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC). Users primarily consume HHC for recreational purposes, but adverse effects have been reported. Given the scant literature on HHC, additional research is needed to better understand its effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>\n                      The present study sought to determine whether 9(R)-hexahydrocannabinol [9(R)-HHC] and 9(S)-hexahydrocannabinol [9(S)-HHC] are psychoactive cannabinoids that share behavioral effects with \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Adult male mice were administered 9(R)-HHC, 9(S)-HHC, or \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC and tested in the tetrad battery to examine cannabimimetic effects (i.e., locomotor suppression, antinociception, hypothermia, and catalepsy). Separate mice were trained to discriminate \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC from the vehicle in drug discrimination and subsequently tested with 9(R)-HHC and 9(S)-HHC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC and 9(R)-HHC produced cannabimimetic effects in all tetrad measures, and 9(R)-HHC fully substituted for \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC in drug discrimination. \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC and 9(R)-HHC showed similar potency across measures, except that 9(R)-HHC produced more hypothermia than \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC. By contrast, 9(S)-HHC only produced cannabimimetic effects in two tetrad measures, was less potent than \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC, and only partially substituted for \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC in drug discrimination.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      9(R)-HHC is likely to possess abuse liability in humans, whereas 9(S)-HHC may produce weak \u0394\n                      <jats:sup>9<\/jats:sup>\n                      -THC-like psychoactivity in humans. The differences in the pharmacology between the two HHC epimers may lead to a range of effects in human users depending on the ratio of the epimers consumed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251330739","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T14:11:22Z","timestamp":1743689482000},"page":"736-743","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0203-4867","authenticated-orcid":false,"given":"Julie A.","family":"Marusich","sequence":"first","affiliation":[{"name":"RTI International, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Prioleau","sequence":"additional","affiliation":[{"name":"United States Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Evaluation Section, Springfield, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luli R.","family":"Akinfiresoye","sequence":"additional","affiliation":[{"name":"United States Department of Justice, Drug Enforcement Administration, Diversion Control Division, Drug and Chemical Evaluation Section, Springfield, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-024-00226-y"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1972.tb07317.x"},{"key":"e_1_3_3_4_1","first-page":"607","article-title":"Development of aggressive behavior in rats by chronic administration of","volume":"8","author":"Carlini EA","year":"1969","unstructured":"Carlini EA, Masur J (1969) Development of aggressive behavior in rats by chronic administration of Cannabis sativa (Marihuana). Life Sciences 8: 607\u2013620.","journal-title":"Cannabis sativa"},{"key":"e_1_3_3_5_1","volume-title":"NFLIS-Drug Snapshot September 2022","author":"Diversion Control Division","year":"2022","unstructured":"Diversion Control Division (2022) NFLIS-Drug Snapshot September 2022. U.S. Department of Justice, U.S. Drug Enforcement Administration."},{"key":"e_1_3_3_6_1","volume-title":"National Forensic Laboratory Information System: NFLIS-Drug 2022 annual report","author":"Diversion Control Division","year":"2023","unstructured":"Diversion Control Division (2023) National Forensic Laboratory Information System: NFLIS-Drug 2022 annual report. U.S. Department of Justice, U.S. Drug Enforcement Administration."},{"key":"e_1_3_3_7_1","unstructured":"EMCDDA (2023) Hexahydrocannabinol (HHC) and related substances. Technical report Luxembourg: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Publications Office of the European Union."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/can.2023.0143"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172918"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X21666230623104624"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050637"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ani7120088"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173467"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100205"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.10.041"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00184a002"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.3c00254"},{"key":"e_1_3_3_18_1","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the Care and Use of Laboratory Animals. Washington, D.C.: National Academies Press (US)."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2024.3"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176549"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3750"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2024.07.001"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38188-5"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73620-0"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3519"},{"key":"e_1_3_3_26_1","volume-title":"World Drug Report 2023","author":"UNDOC","year":"2023","unstructured":"UNDOC (2023) World Drug Report 2023. United Nations Publication."},{"key":"e_1_3_3_27_1","article-title":"Sex, species and age: Effects of rodent demographics on the pharmacology of \u22069-tetrahydrocanabinol","volume":"106","author":"Wiley JL","year":"2021","unstructured":"Wiley JL, Barrus DB, Farquhar CE, et al. (2021) Sex, species and age: Effects of rodent demographics on the pharmacology of \u22069-tetrahydrocanabinol. Progrogress in Neuropsychopharmacology and Biological Psychiatry 106: 110064.","journal-title":"Progrogress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01856-9"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-503-9_12"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.110984"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.07.022"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.225326"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251330739","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251330739","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251330739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:08Z","timestamp":1777507928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251330739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/02698811251330739"],"URL":"https:\/\/doi.org\/10.1177\/02698811251330739","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]}}}